Kangnam Sungshim Hospital
Seoul, South Korea
NCT Number: NCT03701529
The present study is to evaluate the effect of anesthetic agents ( propofol , sevoflurane) on intracranial pressure of female patients undergoing laparoscopic-robotic surgery.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Not applicable
Seoul, South Korea
Anesthetic agents (propofol and sevoflurane)have different effect on intracranial pressure. Sevoflurane when used over 0.5 minimum alveolar concentration, dilates intracranial vasculature and increases intracranial pressure. On the other hand, propofol decreases intracranial blood pressure and intracranial pressure is maintained or decreases.
Optic nerve sheath diameter is a feasible diagnostic tool in evaluating intracranial pressure. Female patients undergoing robot-assisted laparoscopic hysterectomy or myomectomy are evaluated.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1.5-2.5 vol % sevoflurane is used for maintenance of anesthesia.
Other names: sevoflurane anesthesia
2-5 mcg/ml of propofol is used for maintenance of anesthesia.
Other names: propofol anesthesia
Time frame: During the operation.
optic nerve sheath diameter is measured using sonographic probe. (10 minutes after induction of anesthesia/ 5 minutes after pneumoperitoneum and trendelenburg position / 20 minutes after pneumoperitoneum and trendelenburg position / 40 minutes after pneumoperitoneum and trendelenburg position / skin closure)
Hallym University Kangnam Sacred Heart Hospital
Other
Effect of Anesthetic Agents (Propofol, Sevoflurane) on Optic Nerve Sheath Diameter(ONSD) in Patients Undergoing Robot-assisted Laparoscopic Gynecology Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927651
Adenomyosis, Connective Tissue Diseases
Chicago, Illinois, United States
View Trial DetailsNCT01492179
Connective Tissue Diseases, Female Urogenital Diseases
Örebro, Sweden
View Trial DetailsNCT05708950
Adnexal Diseases, Breast Cancer
Santa Monica, California, United States
View Trial DetailsNCT06662435
Adnexal Diseases, Cervical Cancers
Chicago, Illinois, United States
View Trial Details